Actively Recruiting
Robot-assisted Vs. Conventional Occupational Therapy of the Upper Limb in Individuals with Cervical Spinal Cord Injury
Led by Swiss Paraplegic Research, Nottwil · Updated on 2025-03-10
40
Participants Needed
1
Research Sites
147 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn the effects of robot-assisted therapy using the ArmeoSpring on upper limb function compared to conventional occupational therpay in individuals with cervical spinal cord injury (cSCI). The main questions it aims to answer are: \- Which of the two forms of therapy, robot-assisted therapy or conventional occupational therapy, is more effective in terms of improving arm and hand function? The study is designed as a cross-over trial, which means that each participant will receive both therapy forms consecutively, whereas the order is assigned randomly (either robot-assisted therapy first and then occupational therapy, or vice versa). In addition to their clinical routine therapy , participants will: * complete a baseline assessment * practice one therapy form (either robot-assisted or occupational therapy) with one arm for 6 weeks (3 x 30 min per week) * complete a intermediate assessment * practice the other therapy form (either occupational or robot-assisted therapy) with one arm for 6 weeks (3 x 30 min per week) * complete a post assessment * complete a follow-up assessment (if the post assessment was completed prior to 150 days post-injury)
CONDITIONS
Official Title
Robot-assisted Vs. Conventional Occupational Therapy of the Upper Limb in Individuals with Cervical Spinal Cord Injury
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Traumatic or non-traumatic cervical spinal cord injury between more than 16 days and 81 days post-injury during primary rehabilitation at the Swiss Paraplegic Centre
- Neurological injury level between C1 and T1
- American Spinal Injury Association Impairment Scale (AIS) grade A to D
- Upper limb function impairment with GRASSP-QtG score unilateral less than 25 at baseline
- Ability to sit for 60 minutes and perform training with ArmeoSpring
- Stratification parameters available
You will not qualify if you...
- Unable to follow study procedures
- Severe additional neurological disease
- Neurodegenerative or progressive diseases
- Upper limb function impairment due to peripheral nerve lesions
- Severe other medical disease or conditions that could affect study results
- Orthopedic limitations of the upper limb
- Contraindications specific to the device
- Participation in other interventional trials
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Swiss Paraplegic Centre
Nottwil, Canton of Lucerne, Switzerland, 6207
Actively Recruiting
Research Team
M
Mario Widmer, Dr. sc. ETH
CONTACT
C
Chantal Wunderlin
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here